Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that the Company made a poster presentation on the "Safety and Immunogenicity of a Recombinant Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine in Healthy Adults" on Saturday, October 31, 2009 at the 47(th) Annual Meeting of the Infectious Diseases Society of America (IDSA).
Posted By Optiondragon for Myhappytrading.com- The best social network for traders on the internet! Made BY Awesome Traders for Awesome Traders.[More...]
Industrial Services of America, Inc. (IDSA), a recycler of scrap metals based in Louisville, Kentucky, announced second quarter financial results today during regular trading hours. Revenues increased 77% to $34.5 million compared to $19.5 million for the same period last year. Net income surged 102% year over year to $1.66 million, or 46 [...]
Get daily news and insights for the advertising, automotive, energy, financial services, food, health care, media, pharmaceutical, retail, technology, and travel industries.